Vascular nitric oxide resistance in type 2 diabetes

Area of Science:

• Cardiovascular Research
• Endocrinology
• Pharmacology

Background:

• Vascular nitric oxide (NO•) resistance is prevalent in type 2 diabetes (T2D), contributing to cardiovascular complications.
• Impaired NO•-mediated vasodilation in macro- and microvessels is a hallmark of T2D.
• This resistance is linked to increased cardiovascular events and mortality in T2D patients.

Purpose of the Study:

• To review experimental and human evidence of vascular NO• resistance in T2D.
• To discuss the underlying molecular and cellular mechanisms contributing to this resistance.
• To identify potential pharmacological targets for intervention.

Main Methods:

• Analysis of human studies quantifying vascular responses to NO• and NO• donors.
• Review of experimental data elucidating mechanisms of NO• resistance.
• Synthesis of evidence linking hyperglycemia, oxidative stress, and insulin resistance to NO• pathway dysfunction.

Main Results:

• Patients with T2D exhibit significantly reduced endothelium-dependent vasodilation (13-94%) and response to NO• donors (6-42%).
• Key mechanisms include decreased NO• production, increased NO• inactivation, and impaired vascular smooth muscle cell responsiveness.
• Hyperglycemia-induced reactive oxygen species (ROS) overproduction and vascular insulin resistance are critical contributors.

Conclusions:

• Targeting NO• availability, NO• signaling pathways, and ROS production are promising therapeutic strategies.
• Pharmacological interventions could help overcome T2D-induced vascular NO• resistance.
• Addressing these mechanisms may mitigate cardiovascular risks associated with T2D.